DAWN EVANCHO: Open Payments
NPI 1053520486 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 43 payments from 12 companies in 2025. Trend: 2023 $528 · 2024 $1,088 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $276 |
| Amgen Inc. | 10 | $193 |
| ABBVIE INC. | 3 | $164 |
| Axsome Therapeutics, Inc. | 2 | $114 |
| PFIZER INC. | 4 | $84 |
| Abbott Laboratories | 2 | $55 |
| BETA BIONICS, INC. | 1 | $33 |
| Viatris Specialty LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
Products named: OTEZLA, UBRELVY, Wegovy, Symbravo, NURTEC ODT, QULIPTA, Rybelsus, iLet Bionic Pancreas.
Industry payments across NC — which companies pay providers there.
